Moreover, abnormal expression of CEP55 significantly promoted endometrial cancer (EC) progression, whereas down-regulation of CEP55 expression could inhibit proliferation, invasion, migration, delay the cell cycle, and accelerate apoptosis [13]. The gene discussed is CEP55; the disease is endometrial cancer.